California's highest court rules for Gilead in 'duty to innovate' case
By Jonathan Stempel Aug 3 (Reuters) - California's highest court on Monday ruled in favor of Gilead Sciences in a closely watched case addressing whether manufacturers of drugs that are considered safe must try developing drugs that could be safer. 
